Inspire Medical Systems INSP Institutional Ownership

Inspire Medical Systems, Inc. (NYSE:INSP) showed up in the 13F filings of 274 institutional investors as of June 2026.

• Collectively, these holders controlled 129.2% of Inspire Medical Systems's outstanding shares in June 2026, up from 121.5% in March 2026.
• They increased total shares held in Inspire Medical Systems by 23.51% from last quarter, and the number of investors in INSP decreased 22.82% annually.
• During the quarter, 165 of these 274 funds increased positions in INSP, 76 reduced exposure, and 33 held steady.
• In total, institutional investors held 37.27Mn shares in Inspire Medical Systems as of June 2026, up by 7.09Mn shares quarter on quarter, and up 3.82Mn shares year over year.
• BlackRock, Inc. leads ownership in INSP with 4.74Mn shares as of June 30, 2026, equal to 16.43% of outstanding shares.
• The most significant purchases of INSP for the quarter ending June 2026 came from AQR CAPITAL MANAGEMENT LLC (1.55Mn), Nomura Holdings Inc (1.37Mn), Soleus Capital Management, L.P. (1.36Mn), BlackRock, Inc. (1.19Mn), UBS Group AG (1.01Mn).
• The largest sales of INSP for the quarter ending June 2026 came from DEERFIELD MANAGEMENT COMPANY, L.P. (1.41Mn), Morgan Stanley (659.41K), DEUTSCHE BANK AG\ (336.98K), MILLENNIUM MANAGEMENT LLC (292.0K), Royal Bank Of Canada (245.25K).
• According to Business Quant data, leading holders of INSP for June 2026 are BlackRock, Inc. (4.74Mn), WELLINGTON MANAGEMENT GROUP LLP (2.38Mn), VANGUARD PORTFOLIO MANAGEMENT LLC (2.09Mn), Soleus Capital Management, L.P. (1.93Mn), AQR CAPITAL MANAGEMENT LLC (1.86Mn), UBS Group AG (1.65Mn), D. E. Shaw & Co., Inc. (1.47Mn), Nomura Holdings Inc (1.37Mn), DEERFIELD MANAGEMENT COMPANY, L.P. (1.3Mn), VANGUARD CAPITAL MANAGEMENT LLC (1.27Mn).